Finding · as stated by the study, recorded by Coridum · status verified-machine

Finding F-1673

“And CRP level of the subjects was significantly reduced by 20.93% (95%CI: 6.56%, 33.10%), 23.44% (95%CI: 2.77%, 39.39%) and 24.11% (95%CI: 4.21%, 39.69%) for each PM2.5 exposure IQR decrease, on lag1, lag01, and lag02”

Liu Cardiovascular benefits of air purifier in patients with stable coronary artery disease: A randomized single-blind crossover study (2022). Frontiers in public health. Page 5. CKB 8951

Structure

Factor
Particulate matter (PM₂.₅ and PM₁₀)
Intervention
Air purifiers
Setting
home
Study design
double-blind crossover trial in patients with stable coronary heart disease: real against sham portable air purifiers in the bedroom, with personal fine particle exposure measured and inflammation and coagulation markers taken at several lags (class 2)
Effect
difference 20.93 (6.56–33.10) per 1 IQR %
Caveat
the outcome is C-reactive protein, which has no slug in the Vocabulary; the exposure step is one interquartile range of personal fine particle exposure, which the study puts at 22.51 µg/m3, and the value here is for lag1

A Finding records what one published document states, verbatim and with its page. It is not a conclusion of Coridum; see the Claims that build on it.